GET A QUOTE

Chikungunya Virus IgM µ-Capture ELISA Kit

  • Created on the 13 July, 2017.

BACKGROUND

Chikungunya is a member of the Togaviridae family of the alphavirus genus, it can be described as a mosquito-borne viral disease. Some of the many symptoms of this disease include muscle pain, severe joint pain, headache, rash, fever and fatigue. Chikungunya is found all around the world and it shares a number of clinical signs which are similar to dengue and zika virus. The virus is transmitted by a bite from an infected female mosquitoes from one human to another. ELISA assays are one of the most used serological tests which are routinely utilised in order to diagnose Chikungunya virus. Usually either IgM or IgG anti-chikungunya antibodies are used and in the case for IgM, it has been discovered that they are at their highest levels around the 3-5 week period after the onset of the infection and this usually persists for another 2 months.

INTENDED USE

Human Chikungunya virus-IgM ELISA kit is intended for measuring in-vitro quantitative levels of human IgM antibodies to Chikungunya virus using serum and plasma. This assay has a minimum analytical sensitivity limit to a diagn. >90%.

SENSITIVITY

The minimum detection sensitivity level of human Chikungunya virus IgM using this human Chikungunya virus-IgM ELISA kit was to a diagn. >90%. The dynamic assay range for this kit is to a specific cut-off point.

REFERENCES

  1. Evaluation of two IgM rapid immunochromatographic tests during circulation of Asian lineage Chikungunya virus. Southeast Asian J Trop Med Public Health. (2012) 43 (1): 55-61. Kosasih H., et al.
  2. Development and Evaluation of an in-House IgM-Capture ELISA for the Detection of Chikungunya and Its Application to a Dengue Outbreak Situation in Kenya in 2013. Jpn J Infect Dis. (2015) 68 (5): 410-4. Wasonga C., et al.
  3. Cloning, expression and evaluation of diagnostic potential of recombinant capsid protein based IgM ELISA for chikungunya virus. J Virol Methods. (2014) 203: 15-22. Priya R., et al.
  4. Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection. J Med Virol. (2014) 86 (8): 1393-401. Reddy V., et al.
  5. [Dengue, Zika and Chikungunya]. Medicina (B Aires). (2016) 76 (2): 93-7. Spanish. Kantor I.N.
  6. A potent neutralizing IgMmAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis. MAbs. (2015) 7 (6): 1178-94. Lam S., et al.

ADDITIONAL INFORMATION

  • Full Name: Chikungunya Virus IgM µ-Capture ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: daign. >90%

OTHER RELATED ELISA KITS

TESTIMONIALS arrow icon

Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford